Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD)

• Main Authors: Kathryn Kline (Author), Wengen Chen (Author), Michael E. Kallen (Author), Rima Koka (Author), Destiny Omili (Author), Xiaoxuan Fan (Author), Thierry Iraguha (Author), Etse Gebru (Author), Nishanthini Dishanthan (Author), Jillian M. Baker (Author), Kenneth A. Dietze (Author), Jean A. Yared (Author), Kim Hankey (Author), Saurabh Dahiya (Author), Silke V. Niederhaus (Author), Kieron Dunleavy (Author), Nancy M. Hardy (Author), Tim Luetkens (Author), Aaron P. Rapoport (Author), Djordje Atanackovic (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Post-transplant lymphoproliferative disorder (PTLD) is a potentially fatal complication following kidney transplantation, and there is a critical and unmet need for PTLD treatments associated with more pronounced and durable responses. To date, reports on the use of CD19-targeted chimeric antigen re...